Cargando…
Alendronate as an Effective Treatment for Bone Loss and Vascular Calcification in Kidney Transplant Recipients
Kidney transplant recipients develop secondary osteoporosis induced by immunosuppressive medication, with a high risk of fracture, and abdominal aortic calcification (AC) is a known predictor of cardiovascular mortality. In this study of 12 stable kidney recipients, we estimated the preventive effec...
Autores principales: | Okamoto, Masanori, Yamanaka, Shintaro, Yoshimoto, Wataru, Shigematsu, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945217/ https://www.ncbi.nlm.nih.gov/pubmed/24696777 http://dx.doi.org/10.1155/2014/269613 |
Ejemplares similares
-
Vascular calcification progression and its association with mineral and bone disorder in kidney transplant recipients
por: Sun, Li, et al.
Publicado: (2023) -
Lifestyle, Inflammation, and Vascular Calcification in Kidney Transplant Recipients: Perspectives on Long-Term Outcomes
por: Sotomayor, Camilo G., et al.
Publicado: (2020) -
Effect of Statins on the Progression of Coronary Calcification in Kidney Transplant Recipients
por: Yazbek, Daniel Constantino, et al.
Publicado: (2016) -
Vascular calcification on the risk of kidney stone: a meta-analysis
por: Huang, Linxi, et al.
Publicado: (2023) -
Aorto-Iliac Artery Calcification and Graft Outcomes in Kidney Transplant Recipients
por: Benjamens, Stan, et al.
Publicado: (2021)